Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators.
about
Venous thromboembolic diseaseHeparin-induced thrombocytopenia: an updateLepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3A comparison of lepirudin and argatroban outcomesImpact of thromboprophylaxis across the US acute care settingTreatment of heparin-induced thrombocytopenia.Hirudin therapy during thrombolysis for venous thrombosis in heparin-induced thrombocytopenia.Lepirudin as a safe alternative for effective anticoagulation in patients with known heparin-induced thrombocytopenia undergoing percutaneous coronary intervention: case reports.Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.Anticoagulation for acute coronary syndromes and percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.Drug-induced and drug-dependent immune thrombocytopenias.Therapeutic considerations in the management of patients with heparin-induced thrombocytopenia.Direct antithrombin agents ameliorate disseminated intravascular coagulation in suspected heparin-induced thrombocytopenia thrombosis syndrome.Tackling the devastating effects of heparin-induced thrombocytopenia.Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia.Lepirudin use in a neonate with heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: pathogenesis and management.Laboratory diagnosis of heparin-induced thrombocytopenia and monitoring of alternative anticoagulantsDiagnosis and management of heparin-induced thrombocytopenia.Coronary artery stent thrombosis associated with heparin-induced thrombocytopenia: case report and review of the literature.Direct thrombin inhibitors: pharmacology and clinical relevance.Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After ThrombocTransitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR).Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.Treatment of heparin-induced thrombocytopenia in cardiovascular patients.Treatment of heparin-induced thrombocytopenia with drotrecogin alfa (activated).Argatroban for suspected heparin-induced thrombocytopenia: contemporary experience at a large teaching hospital.The management of heparin-induced thrombocytopenia.When heparin causes thrombosis: significance, recognition, and management of heparin-induced thrombocytopenia in dialysis patients.Lepirudin for anticoagulation in patients with heparin-induced thrombocytopenia treated with continuous renal replacement therapy.Heparin-induced thrombocytopenia: treatment options and special considerations.Testing for heparin-induced thrombocytopenia: are we there yet?Should patients be informed about the risk of heparin-induced thrombocytopenia before prolonged low-molecular-weight heparin thromboprophylaxis post-trauma/orthopedic surgery?Rotational thrombelastometry for the bedside monitoring of recombinant hirudin.[Direct thrombin inhibitors: pharmacology and application in cardiovascular anesthesia].Rivaroxaban--an oral, direct Factor Xa inhibitor--has potential for the management of patients with heparin-induced thrombocytopenia.Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia.Thrombocytopenia associated with antithrombotic therapy in patients with cardiovascular diseases: diagnosis and treatment.Dosing patterns and outcomes in African American, Asian, and Hispanic patients with heparin-induced thrombocytopenia treated with argatroban.Current concepts review: heparin-induced thrombocytopenia.
P2860
Q24631121-D4E0A29F-9BC3-47FB-8BB9-38FBA9F9CBC0Q24815767-BEBC3C59-6444-472D-82BD-59FBA45808A6Q28278419-5FB76EAE-1D56-45D1-8DD2-97E801B2C064Q28278668-E7D727C8-E301-42E9-B3D3-785305DD8DF4Q28651190-F3396D88-D3C3-4B39-ABC5-BAE9216E6300Q31042575-1236216C-70F6-4474-BE61-E61A96812380Q33336136-AA50C535-1112-4AD2-8599-40E573AFCDE9Q33336698-B7C34F50-F4DA-4605-9A12-D512B9745028Q33336836-8E7AD094-D3A3-4F0C-96E3-36D1E4683A4EQ33338529-DC1F2DEE-6D8F-45A8-8933-001448E69B50Q33339739-316F36FE-1256-4DBB-9235-487800CF6B99Q33343054-815DC191-29E1-4562-8B6B-F018EFF9FCDCQ33344541-0F2B2A92-CFCE-4FE2-8AAE-7450890D3E7AQ33345517-8E2425F1-AF23-4D11-869F-1C56C75E4784Q33346149-E361D690-879B-4942-BD26-F90C916A8F6EQ33346256-4BA6F0C8-4598-446C-93D2-D48BB6528787Q33348049-C3C577F0-BA13-445E-987C-1C06C31FAE04Q33349870-F679033E-81A1-490B-ABC2-1CA616D03689Q33365985-BBA8B320-2A8D-4365-B3BA-C3BD56AA0DC2Q33366197-4F651045-8B77-447F-8776-8A71D7C9C4FDQ33366516-3C7D7D70-63AD-47C0-BC9C-C74808C439D3Q33366916-9AFCE9DE-E0CF-4BA5-B3C2-B76E6D3D91A0Q33367685-159E8D7B-54C6-4CCE-9F20-0DC8693B085BQ33369330-2EB0E04B-91D1-49AB-8A27-7CA0E4035C50Q33370137-F5362304-3FC2-476A-99E1-718F79F7DE66Q33370372-2D8BD8D8-C72B-43D4-BB49-C74D2C4760E7Q33370566-C825AC3B-F9C5-493F-8753-974F69C9C550Q33371013-57DF1DFC-A75E-4075-986E-C3B86B1885A8Q33372179-CC07AD37-B1D3-4B90-863B-63921DD5CC40Q33373306-80963DF8-DCFC-4620-BACC-03052E167B6FQ33374658-228138D8-1C05-4130-9C5F-865246B227F3Q33374916-530F3F68-5A5D-4C3C-B90D-680450FBD79BQ33376013-C5D8E00A-FEE9-4509-A2A8-B1B8CB97C5D7Q33378329-AD52410C-2352-484A-ADA8-C0A6A858BDFDQ33378823-5A5BD2B8-FF38-4B87-9A4A-DE5BC3CBEAF1Q33380570-6C3C518E-F6B1-4890-A42E-A7A2EC3867EEQ33380931-5D9662E6-570D-4001-8F05-511F009483F3Q33381366-50DC5A29-DDBB-4373-BBB1-5AAF2792F7DEQ33382034-307C9477-F001-4034-BAE6-EC6DEA4C1519Q33382108-DAC722A8-7582-48D8-89EE-3930FCD01F0D
P2860
Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Lepirudin (recombinant hirudin ...... nia Study (HAT) investigators.
@ast
Lepirudin (recombinant hirudin ...... nia Study (HAT) investigators.
@en
Lepirudin
@nl
type
label
Lepirudin (recombinant hirudin ...... nia Study (HAT) investigators.
@ast
Lepirudin (recombinant hirudin ...... nia Study (HAT) investigators.
@en
Lepirudin
@nl
prefLabel
Lepirudin (recombinant hirudin ...... nia Study (HAT) investigators.
@ast
Lepirudin (recombinant hirudin ...... nia Study (HAT) investigators.
@en
Lepirudin
@nl
P2093
P356
P1433
P1476
Lepirudin (recombinant hirudin ...... enia Study (HAT) investigators
@en
P2093
A Greinacher
B Kemkes-Matthes
U Janssens
P304
P356
10.1161/01.CIR.100.6.587
P407
P50
P577
1999-08-01T00:00:00Z